08 10月 2018 by admin in UncategorizedComments Crescendo Biologics appoints SVP CMC, Dr Richard Williams, and new CDMO partner, as it advances towards the clinic
02 10月 2018 by admin in UncategorizedComments Crescendo Biologics shortlisted for Private Financing Deal of the Year at 2018 Scrip Awards
24 9月 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Andrew Partridge as Executive Vice President, Chief Commercial Officer
24 9月 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Andrew Partridge as Executive Vice President, Chief Commercial Officer
20 9月 2018 by admin in UncategorizedComments Crescendo Biologics shortlisted for Lifestars Awards 2018
19 9月 2018 by admin in UncategorizedComments Crescendo Biologics shortlisted for Cambridge Independent Science and Technology Awards 2018
18 9月 2018 by admin in UncategorizedComments resTORbio Appoints Meredith Manning as Chief Commercial Officer
11 9月 2018 by admin in UncategorizedComments Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer
06 9月 2018 by admin in UncategorizedComments Centrexion Therapeutics Announces CNTX-4975 Data Presentation at PAINWeek 2018 National Conference
04 9月 2018 by admin in UncategorizedComments TEMPEST THERAPEUTICS NAMES DR. GINNA LAPORT CMO – Dr. Alicia Levey promoted to CBO –
